Detection of tyrosinase mRNA by reverse transcription-polymerase chain reaction in melanoma sentinel nodes

Annals of Surgical Oncology

Volumn 6, Issue 3, 1999, Pages 232-240

  Bieligk, Samuel C ^a,c   Ghossein, Ronald ^b   Bhattacharya, Satyajit ^b   Coit, Daniel G ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Reverse transcriptase polymerase chain reaction; Sentinel lymph node; Tyrosinase mRNA

Indexed keywords

MESSENGER RNA; MONOPHENOL MONOOXYGENASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE;

EID: 0032896934     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-999-0232-z     Document Type: Article

References (31)

1. Sim FH, Taylor WF, Pritchard DJ, Soule EH. Lymphadenectomy in the management of stage I malignant melanoma: a prospective randomized study. Mayo Clin Proc 1986;61:697-705.
2. Veronesi U, Adamus J, Bandiera DC, et al. Inefficacy of immediate node dissection in stage I melanoma of the limbs. N Engl J Med 1977;297:627-30.
3. Veronesi U, Adamus J, Bandiera DC, et al. Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 1982;49:2420-30.
4. Balch CM, Soong SJ, Bartolucci AA, et al. Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996;224:255-66.
5. Dickler MN, Coit DG, Meyers ML. Adjuvant therapy of malignant melanoma. Surg Oncol Clin North Am 1997;6:793-812.
6. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
7. Multicenter Selective Lymphadenectomy Trial. National Cancer Institute Grant PO1-CA29605-12.
8. Brady MS, Coit DG. Lymphatic mapping in the management of the patient with cutaneous melanoma. The Cancer Journal 1997;10: 87-93.
9. Cochran AJ, Wen DR, Morton DL. Occult tumor cells in the lymph nodes of patients with pathological stage I malignant melanoma. Am J Surg Pathol 1988;12:612-8.
10. Bieligk SC, Klimstra DS, Rosai J, Coit DG. The detection of micrometastases in melanoma sentinel nodes by step sectioning and immunohistochemical staining. Melanoma Res 1997;7(Suppl 1):S125 [Abstract].
11. Ghossein RA, Coit DG, Brennan MF, et al. Prognostic significance of peripheral blood and bone marrow tyrosinase messenger RNA in malignant melanoma. Clin Cancer Res 1998;4:419-28.
12. Hoon DSB, Wang Y, Dale PS, et al. Detection of occult melanoma cells in blood with a multiple-marker polymerase chain reaction assay. J Clin Oncol 1995;13:2109-16.
13. Moreno JG, Croce CM, Fisher R, et al. Detection of hematogenous micrometastases in patients with prostate cancer. Cancer Res 1992; 52:6110-2.
14. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet 1991; 338:1227-9.
15. Kawasaki ES, Clark SS, Coyne MY, et al. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci USA 1988;85:5698-702.
16. Tada M, Omata M, Kawai S, et al. Detection of ras gene mutations in pancreatic juice and peripheral blood of patients with pancreatic adenocarcinoma. Cancer Res 1993;53:2472-4.
17. Wang X, Heller R, Van Voorhis N, et al. Detection of submicroscopic lymph node metastases with polymerase chain reaction in patients with malignant melanoma. Ann Surg 1994;220:768-74.
18. Reintgen D, Balch CM, Kirkwood J, Ross MI. Recent advances in the care of the patient with malignant melanoma. Ann Surg 1997; 225:1-14.
19. Van der Velde-Zimmermann D, Roijers JFM, Bouwens-Rombouts A, et al. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients. Am J Pathol 1996;149:759-64.
20. Battyani Z, Xerri L, Hassoun J, Bonerandi J-J, Grob J-J. Tyrosinase gene expression in human tissues. Pigment Cell Res 1993;6: 400-8.
21. Naber SP, Smith LL, Wolfe HJ. Role of the frozen tissue hank in molecular pathology. Diagn Mol Pathol 1992;1:73-9.
22. Ben-Ezra J, Johnson DA, Rossi J, Cook N, Wu A. Effect of fixation on the amplification of nucleic acids from paraffin embedded material by the polymerase chain reaction. J Histochem Cytochem 1991;39:351-4.
23. Fleming ID, Cooper JS, Henson DE, et al., eds. American Joint Committee on Cancer cancer staging manual, ed. 5. Philadelphia: JB Lippincott, 1997.
24. McMasters KM, Reintgen DS, Ross MI, Edwards MJ, Cerrito P. Sunbelt Melanoma Trial: A multicenter trial of adjuvant interferon alfa-2b for melanoma patients with early lymph node metastasis detected by lymphatic mapping and sentinel lymph node biopsy. Louisville, KY: 1996.
25. Mattano LA, Moss TJ, Emerson SG. Sensitive detection of rare circulating neuroblastoma cells by the reverse transcriptase-polymerase chain reaction. Cancer Res 1992;52:4701-5.
26. Kaplan JC, Kahn A, Chelly J. Illegitimate transcription: its use in the study of inherited disease. Hum Mutat 1992;1:357-60.
27. Mellado B, Colomer D, Castel T, et al. Detection of circulating neoplastic cells by reverse-transcriptase polymerase chain reaction in malignant melanoma: association with clinical stage and prognosis. J Clin Oncol 1996;14:2091-7.
28. Bautista NC, Cohen S, Anders KH. Benign melanocytic nevus cells in axillary lymph nodes: a prospective incidence and immunohistochemical study with literature review. Am J Clin Pathol 1994;102:102-8.
29. Carson KF, Wen D-R, Li P-X, et al. Nodal nevi and cutaneous melanomas. Am J Surg Pathol 1996;20:834-40.
30. Buzaid AC, Balch CM. Polymerase chain reaction for detection of melanoma in peripheral blood: too early to assess clinical value. J Natl Cancer Inst 1996;88:569-70.
31. Reintgen D, Albertini J, Berman C, et al. Accurate nodal staging of malignant melanoma. Cancer Control, J Moffitt Cancer Center 1995;2:405-14.